Fig. 5From: Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trialSchematic before and after lung CT scan of patients. A and B are representative images of a patient in intervention group (before and after treatment)/C and D are representative images of a patient in control group (before and after study)Back to article page